BTRX-246040
Investigational drug
BTRX-246040 | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
BTRX-246040 is an investigational drug that acts as a selective antagonist of the nociceptin receptor (NOP receptor). It is being studied for its potential use in the treatment of various central nervous system disorders, including depression and anxiety.
Pharmacology[edit | edit source]
BTRX-246040 is a small molecule that selectively binds to the nociceptin receptor, which is a member of the opioid receptor family. Unlike traditional opioid receptors, the nociceptin receptor does not bind to classical opioids like morphine or heroin. Instead, it binds to the endogenous peptide nociceptin, also known as orphanin FQ.
The nociceptin receptor is involved in a variety of physiological processes, including the modulation of pain, mood, and stress responses. By antagonizing this receptor, BTRX-246040 may help to alleviate symptoms of depression and anxiety without the addictive potential associated with traditional opioids.
Development[edit | edit source]
BTRX-246040 was developed by BlackThorn Therapeutics, a company focused on developing treatments for neurobehavioral disorders. The drug is currently in the early stages of clinical development, with ongoing studies to evaluate its safety, tolerability, and efficacy in humans.
Mechanism of Action[edit | edit source]
The mechanism of action of BTRX-246040 involves the selective blockade of the nociceptin receptor. This blockade is thought to modulate neurotransmitter systems in the brain that are implicated in mood regulation and stress response. By inhibiting the action of nociceptin, BTRX-246040 may enhance the activity of other neurotransmitter systems, such as the serotonin and dopamine systems, which are often dysregulated in mood disorders.
Potential Applications[edit | edit source]
BTRX-246040 is being investigated for its potential use in treating a range of neuropsychiatric conditions. These include:
The unique mechanism of action of BTRX-246040 offers a novel approach to treating these conditions, particularly for patients who do not respond to traditional antidepressants or anxiolytics.
Safety and Tolerability[edit | edit source]
Preliminary studies suggest that BTRX-246040 is well-tolerated in humans, with a safety profile that is distinct from that of traditional opioids. Common side effects observed in clinical trials include mild gastrointestinal disturbances and transient headache.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD